Explore epigenetic therapy of using histone deacetylase inhibitors in the Angelman Syndrome mouse model
Neuregulin-dependent alterations in glutamate receptor function and LTP in Angelman Syndrome model mice
A combined molecular and electrophysiological approach to understanding cerebellar defects in Angelman syndrome
Therapeutic effectiveness of levodopa in the treatment of seizures and motor defects using the Angelman Syndrome mouse model
The ubiquitin ligase E6-AP/UBE3A targets the polycomb repressive complex proteins Ring 1B and Bmi1 to ubiquitination and subsequent degradation: Structural and functional implications, and possible relationship to the pathogenesis of Angelman syndrome